September 2018

Meet the Professor 
Philippe Lambin: how advances in imaging impact precision radiation oncology?
Julia Wang
Precision Cancer Medicine  
2018,  
1:
17  
Mini-Review 
What is the best drug as a front-line treatment for EGFR activating mutation?
Hidetaka Uramoto
Precision Cancer Medicine  
2018,  
1:
16  
Meet the Professor 
Bhadrasain Vikram: future road of radiation—radiomics and genomics will play important roles
Gin Li
Precision Cancer Medicine  
2018,  
1:
15  
Editorial 
PLX51107, a promising novel bromodomain and extra-terminal inhibitor in chronic lymphoid leukemia treatment
Claes Wahlestedt, Ines Lohse
Precision Cancer Medicine  
2018,  
1:
14  
Editorial 
AR-V7 and treatment selection in advanced prostate cancer: are we there yet?
Diogo A. Bastos, Emmanuel S. Antonarakis
Precision Cancer Medicine  
2018,  
1:
13  
Editorial 
Fatty acids: from adipocytes to cancer cells
Hiu Yee Kwan
Precision Cancer Medicine  
2018,  
1:
12  
Meet the Professor 
Dr. Shankar Siva: combination of immunotherapy and stereotactic ablative radiotherapy may be a better choice for cancer patients
Gin Li
Precision Cancer Medicine  
2018,  
1:
11